Astera Labs, Inc. (ALAB) — Insider Trading

AI-Powered SEC Filing Analysis

Latest Insider Trading Filed: 2026-04-21

Key Insights

Director Stefan Dyckerhoff executed substantial sales totaling approximately 24,765 shares across multiple transactions on April 17-20, 2026, at prices around $175, suggesting programmed liquidation rather than opportunistic selling.
The sales were conducted under a Rule 10b5-1 trading plan adopted on December 1, 2025, indicating this was a pre-planned divestment strategy established months in advance, reducing concerns about negative near-term outlook.
Post-transaction holdings remain significant at approximately 67,144 direct shares plus substantial indirect holdings through trusts and partnerships (totaling ~450,000+ shares across all entities), suggesting the director retained substantial confidence in the company despite the sales.
The weighted average sale price of $175.00-$175.12 across both transaction dates shows minimal price volatility during the sale period, indicating stable market conditions and no apparent rushed exit timing.

Want the newest filings?

This analysis covers the filing from 2026-04-21. New 10-K, 10-Q and 8-K filings are analyzed the moment they are released — exclusively in the app.

Download on the App Store Open in app →

Earlier Insider Trading filings

Filed: 2026-04-21

CEO Mohan Jitendra executed a substantial pre-planned divestment of approximately 390,000 shares over April 17-20, 2026, through a Rule 10b5-1 trading plan established December 1, 2025, suggesting systematic portfolio rebalancing rather than emergency liquidity needs.
The sales occurred at progressively higher prices ranging from $167.29 to $175.81 per share, generating approximately $68-70 million in proceeds, while the CEO maintained significant indirect beneficial ownership of approximately 4.1 million shares through various trusts.
Direct ownership remains substantial at 1.45 million shares plus indirect holdings across multiple trust vehicles (Living Trust, 2021 Trust 1 & 2, 2022 Trust 1 & 2), indicating continued confidence in the company despite the large stock sale.
The pre-planned nature of these sales (established 4.5 months in advance via Rule 10b5-1 plan) minimizes insider trading concerns and suggests the executive anticipated stable or rising stock valuations during the execution window.

Filed: 2026-04-16

Insider Jitendra Mohan, the CEO, sold 2,967 shares of Astera Labs stock on 04/15/2026, indicating potential profit-taking.
Mohan still holds a significant direct and indirect stake of over 7.5 million shares, suggesting he remains bullish on the company's long-term prospects.
The sales were made pursuant to a pre-planned 10b5-1 trading plan, which may help mitigate concerns about insider trading.

Filed: 2026-04-14

The CEO sold a large number of shares (123,750) in multiple transactions on April 10, 2026, likely for estate planning or liquidity purposes.
The CEO still holds a significant equity stake in the company, with over 4.4 million shares beneficially owned through various trust vehicles.
The CEO's selling appears to be part of a pre-planned 10b5-1 trading plan, which may help mitigate concerns about insider selling.

Filed: 2026-04-03

Philip Mazzara, the General Counsel and Secretary of Astera Labs, Inc., has conducted a series of stock sales totaling 10,000 shares on April 1, 2026.
The sales were executed pursuant to a Rule 10b5-1 trading plan that Mazzara adopted on May 29, 2025, suggesting a pre-planned strategy.
The sales were executed at weighted average prices ranging from $106.34 to $110.35 per share, generating total proceeds of approximately $1.1 million.

Filed: 2026-04-03

Insider Manuel Alba-Marquez has engaged in significant selling of Astera Labs stock, disposing of over 1.4 million shares through multiple transactions on April 1, 2026.
The sales were executed pursuant to a pre-established 10b5-1 trading plan, suggesting they were part of a planned liquidity strategy rather than a sudden divestment.
Alba-Marquez retains a substantial indirect beneficial ownership of over 1.4 million shares through the Alba Trust, as well as a smaller direct ownership of 2,351 shares and indirect ownership of 5,000 shares through his spouse and Casa Alameda 2007, LLC.

Filed: 2026-03-19

The CEO Jitendra Mohan has reported selling a significant number of shares of Astera Labs stock, totaling over 200,000 shares sold on March 17, 2026 at prices ranging from $125.07 to $134.67.
Mohan's sales appear to be part of a pre-planned 10b5-1 trading plan, suggesting the transactions were not opportunistic but rather systematic in nature.
The large volume and consistent selling pattern over the course of the day may indicate Mohan is reducing his personal stake in the company, though he still maintains a substantial indirect beneficial ownership position through various trusts.

Other reports for Astera Labs, Inc.

Annual Report Current Report

Important Information

AI-generated analysis is for informational purposes only. Always read original SEC filings and consult with qualified professionals before making investment decisions.